Clinical Trial Update: Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants [NA]

View source ↗

Summary

This clinical trial evaluating indomethacin or ibuprofen for closing patent ductus arteriosus in extremely low birth weight infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)
• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Taipei Medical University Hospital | Conditions: Patent Ductus Arteriosus | NA | Status: COMPLETED